Foghorn Therapeutics (FHTX) Amortization of Deferred Charges (2019 - 2021)

Foghorn Therapeutics' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $58000.0 for Q4 2021.

• In Q4 2021, Amortization of Deferred Charges fell 1.69% year-over-year to $58000.0; the TTM figure through Sep 2022 stood at $58000.0 (down 81.82% YoY), while the FY2021 annual figure was $318000.0, up 33.61% from the prior year.
• Amortization of Deferred Charges was $58000.0 for Q4 2021 at Foghorn Therapeutics, down from $88000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $88000.0 in Q3 2021 to a low of $41000.0 in Q4 2019.
• Historically, Amortization of Deferred Charges has averaged $66333.3 across 3 years, with a median of $62000.0 in 2020.
• Biggest YoY gain for Amortization of Deferred Charges was 66.04% in 2021; the steepest drop was 1.69% in 2021.
• A 3-year view of Amortization of Deferred Charges shows it stood at $41000.0 in 2019, then jumped by 43.9% to $59000.0 in 2020, then dropped by 1.69% to $58000.0 in 2021.
• The last three Amortization of Deferred Charges figures came in at $58000.0 (Q4 2021), $88000.0 (Q3 2021), and $87000.0 (Q2 2021), per Business Quant data.